Citadel Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-77,599
| Closed | -$144K | – | 6826 |
|
|
2023
Q1 | $144K | Buy |
77,599
+68,655
| +768% | +$127K | ﹤0.01% | 4764 |
|
|
2022
Q4 | $9.93K | Sell |
8,944
-1,446,918
| -99% | -$1.61M | ﹤0.01% | 5686 |
|
|
2022
Q3 | $3.41M | Sell |
1,455,862
-239,005
| -14% | -$559K | ﹤0.01% | 2219 |
|
|
2022
Q2 | $5.14M | Sell |
1,694,867
-6,687
| -0.4% | -$20.3K | ﹤0.01% | 1836 |
|
|
2022
Q1 | $11.6M | Sell |
1,701,554
-27,482
| -2% | -$187K | ﹤0.01% | 1294 |
|
|
2021
Q4 | $14.4M | Buy |
1,729,036
+4,785
| +0.3% | +$40K | ﹤0.01% | 1168 |
|
|
2021
Q3 | $12.8M | Sell |
1,724,251
-236,350
| -12% | -$1.76M | ﹤0.01% | 1208 |
|
|
2021
Q2 | $13.3M | Buy |
1,960,601
+54
| +0% | +$367 | ﹤0.01% | 1229 |
|
|
2021
Q1 | $20.1M | Buy |
1,960,547
+229,198
| +13% | +$2.35M | ﹤0.01% | 933 |
|
|
2020
Q4 | $12.1M | Buy |
1,731,349
+1,694,224
| +4,564% | +$11.9M | ﹤0.01% | 1147 |
|
|
2020
Q3 | $303K | Sell |
37,125
-416,777
| -92% | -$3.4M | ﹤0.01% | 3829 |
|
|
2020
Q2 | $3.13M | Buy |
453,902
+412,056
| +985% | +$2.84M | ﹤0.01% | 1860 |
|
|
2020
Q1 | $198K | Buy |
41,846
+30,230
| +260% | +$143K | ﹤0.01% | 4087 |
|
|
2019
Q4 | $101K | Buy |
11,616
+947
| +9% | +$8.23K | ﹤0.01% | 4287 |
|
|
2019
Q3 | $36K | Sell |
10,669
-15,335
| -59% | -$51.7K | ﹤0.01% | 4415 |
|
|
2019
Q2 | $129K | Sell |
26,004
-52,709
| -67% | -$261K | ﹤0.01% | 4223 |
|
|
2019
Q1 | $488K | Sell |
78,713
-7,845
| -9% | -$48.6K | ﹤0.01% | 3393 |
|
|
2018
Q4 | $292K | Sell |
86,558
-132,872
| -61% | -$448K | ﹤0.01% | 3625 |
|
|
2018
Q3 | $1.43M | Sell |
219,430
-314,941
| -59% | -$2.05M | ﹤0.01% | 2447 |
|
|
2018
Q2 | $4.09M | Buy |
534,371
+241,786
| +83% | +$1.85M | ﹤0.01% | 1568 |
|
|
2018
Q1 | $6.54M | Buy |
+292,585
| New | +$6.54M | ﹤0.01% | 1148 |
|
|
2017
Q3 | – | Sell |
-14,245
| Closed | -$200K | – | 4252 |
|
|
2017
Q2 | $200K | Buy |
+14,245
| New | +$200K | ﹤0.01% | 3169 |
|